A nanovehicle allows drugs to reach damaged cells and destroy them
TV3's "Telenotícies" programme interviewed Miguel Rovira, a PhD student at IRB Barcelona and the first author of a recent study published in the journal EMBO Molecular Medicine. In this study, the scientists designed a nano-carrier to release drugs into damaged cells.
Link to TV3
Link to TV3 (vídeo)
Related content
News
Researchers at IRB Barcelona discover a new mechanism in estrogen receptor-positive breast cancer cells.
The inhibition of CPEB2, a key factor in the estrogen signalling pathway, causes cancer cells to proliferate less and protects mice against luminal breast cancer.
The journal The Scientist has published an interview with Manuel Serrano, ICREA researcher and head of the Cell Plasticity and Disease Lab at IRB Barcelona, about studies into cell aging done in recent years. In the 1950s, the scientist Leonard Hayflick did a series of studies in which he demonstrated that cells enter what is known as a “senescent” state. Initially, the scientific community rejected this concept, considering it irrelevant for living organisms.
Published in the journal Nature Cancer, the study analyses how genetic alterations in tumour cells prevent the correct degradation of the proteins involved in tumour development and growth, thereby leading to abnormal cell behaviour.
A machine-learning model has allowed the scientists to obtain the most extensive annotation of the ubiquitin-mediated protein degradation system.
The analysis proposes a potential new clinical approach for cancer through the inhibition of oncoproteins with impaired degradation systems.
